Monash Research Office (MRO)

Lung Cancer Research Program (LCRP) FY12 – Idea Development Award

The LCRP Idea Development Award mechanism is being offered for the first time in FY12. The Idea Development Award is designed to promote new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This mechanism supports conceptually innovative, high–risk/high–reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well–formulated, testable hypothesis based on strong scientific rationale.

Eligibility: The PI must be an independent investigator at or above the level of Assistant Professor (or equivalent), and be within 10 years of his/her first faculty appointment (or equivalent) by the time of the application submission deadline. Funding: The maximum period of performance is 2 years. The maximum allowable direct costs for the entire period of performance are $350,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Preproposal) : May 30, 2012. Preproposal is required; Application submissionis by invitation only. Application: September 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 19/04/2012

Lung Cancer Research Program (LCRP) FY12 – Translational Research Partnership Award

The LCRP Translational Research Partnership Award mechanism is being offered for the first time in FY12. The key initiative of the Translational Research Partnership Award is to encourage partnerships between clinicians and laboratory scientists that will accelerate the movement of promising ideas in lung cancer into clinical applications. This award supports the development of translational research collaborations between two independent, faculty level (or equivalent) investigators to address a central problem or question in lung cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a laboratory scientist and the other must be a clinician, and it should be clear that both have had equal intellectual input into the design of the research project. Multi–institutional partnerships are encouraged but not required. At least one member of the partnership must have experience either in lung cancer research or lung cancer patient care. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this award mechanism. Submissions from and partnerships with investigators at Military Medical Treatment Facilities, military labs, the Department of Veterans Affairs (VA) Medical Centers and research laboratories, and commercial organizations are encouraged.

Eligibility: Each PI must be an independent investigator at or above the level of Assistant Professor (or equivalent). Funding: The maximum period of performance is 3 years. A separate award will be made for each PI, even if the PIs are at the same organization. The maximum allowable combined total direct costs for the entire period of performance are $900,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Preproposal) : May 30, 2012. Preproposal is required; Application submissionis by invitation only. Application: September 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 19/04/2012

Bower Award and Prize for Achievement in Science 2013

The Franklin Institute seeks nominations for the 2013 Bower Award and Prize for Achievement in Science of individuals who have made significant scientific contributions that have advanced our understanding of chemistry on the nanoscale and/or its applications.

Specific research areas suggested for the 2013 Bower Award and Prize for Achievement in Science include, but are not limited to: quantum dots, semiconductor nanomaterials, nanosized metal particles and catalysts, nanochemistry in medicine, nanoscale assemblies, nanochemistry in biological imaging, and nanochemistry in energy research.

Notice of intent to nominate is encouraged by March 31, 2012 and the complete nomination by May 31 2012.

Last updated: 30/03/2012

2012 CE.R.I.E.S. Research Award

Chanel Research and Technology is honored to announce the launch of the 2012 CE.R.I.E.S. Research Award. The CE.R.I.E.S. is the research center on healthy skin of Chanel Research and Technology. It aims to better understand the structure and function of healthy skin through clinical studies carried out at its laboratories and fundamental research projects performed in collaboration with leading researcher worldwide. Chanel Research and Technology is calling for international applications for its 2012 CE.R.I.E.S. Award for healthy skin research.

The objective of Chanel Research and Technology is to develop innovative solutions to meet the needs, desires and dreams of each woman in her quest for singular beauty. The heart of our culture is a culture of "multidisciplinary project", a culture that opens up the possibility for each expertise.

The CE.R.I.E.S. Research Award is an annual initiative supported by Chanel Research and Technology whose purpose is to honor a scientist with a proven track record in basic or clinical research and to help fund a future project.

The subject area of the 40,000 € CE.R.I.E.S. Research Award is the physiology or biology of healthy skin and/or its reactions to environmental factors. The Awardee will be selected by an international jury consisting of the members of the CE.R.I.E.S. Scientific Advisory Board.

Last updated: 20/04/2012

Peer Reviewed Medical Research Program (PRMRP) – Clinical Trial Award FY12

The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY12 PRMRP topic areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof–of–concept (i.e., pilot, first in human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large–scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the health care needs of the military service members, veterans, and/or beneficiaries; however, the use of military populations is not required.

Funding: The maximum period of performance is 5 years. The maximum allowable direct costs for the entire period of performance are –2.2M plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Applications (LOI) due: June 6, 2012. Applicants due: June 26, 2012

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 03/04/2012

Peer Reviewed Medical Research Program (PRMRP) – Technology/Therapeutic Development Award FY12

The PRMRP Technology/Therapeutic Development Award is product–driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, patient care, and/or quality of life, in at least one of the Congressionally directed FY12 PRMRP topic areas. Products in development should be responsive to the health care needs of military service members, veterans, and/or beneficiaries. The product(s) to be developed may be pharmacologic agents (drugs or biologics), devices, and/or clinical guidance for standard of care. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to clinical trials and/or delivery to the military or civilian market after the completion of the PRMRP award.

Funding: The maximum period of performance is 3 years. The maximum allowable direct costs for the entire period of performance are $1.5M plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Applications (LOI) due: June 6, 2012. Applicants due: June 26, 2012

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 03/04/2012

Prostate Cancer Research Program (PCRP) – Exploration–Hypothesis Development Award FY12

The PCRP Exploration – Hypothesis Development Award mechanism was first offered in FY03. Since then, 1,427 Exploration – Hypothesis Development Award applications have been received, and 178 have been recommended for funding. The Exploration – Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high–gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based or initial proof–of–principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described.

Funding: The maximum period of performance is 1 year. The maximum allowable direct costs for the entire period of performance are $75,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Letter of Intent) due: June 6, 2012. Application due: June 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 03/04/2012

Prostate Cancer Research Program (PCRP) – Physician Research Training Award FY12

The PCRP Physician Research Training Award (PRTA) mechanism was first offered in FY03. Since then, 134 PRTA applications have been received, and 58 have been recommended for funding. The PRTA supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. This award emphasizes equally the quality of both the research and the training proposed. The trainee is considered the Principal Investigator (PI) of the application. All applications for the PRTA are to be written by the PI, with appropriate direction from the mentor(s). The PI must demonstrate a commitment to a career as an investigator at the forefront of prostate cancer research and clinical practice; however, the PI is not required to have previous prostate cancer research experience. Applications must include a robust description of an individualized, prostate cancer–focused training plan that will provide the PI with experience in key areas relevant to the proposed work and foster the PI7#39;s development as a prostate cancer researcher.

Funding: The maximum period of performance is 4 years, and the minimum is 3 years. The maximum allowable direct costs for the entire period of performance are $520,000 plus indirect costs. The maximum allowable direct costs amount per year is $130,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Letter of Intent) due: June 6, 2012. Confidential Letters of Recommendation due: June 20, 2012. Application due: June 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 04/04/2012

Prostate Cancer Research Program (PCRP) – Postdoctoral Training Award FY12

The PCRP Postdoctoral Training Award mechanism was first offered as the Postdoctoral Traineeship Award in FY99 and was incorporated into the Prostate Cancer Training Award in FY06–FY10. In total, 1,183 Postdoctoral Training Award applications have been received, and 397 have been recommended for funding. The Postdoctoral Training Award supports prostate cancer research training opportunities for recent doctoral graduates. These awards primarily provide salary support for the Principal Investigator (PI); the postdoctoral trainee is considered the PI of the application. The PI must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of prostate cancer research; however, the PI is not required to have previous prostate cancer research experience. Applications must include at least one mentor, appropriate to the proposed training and research project, who has experience in prostate cancer research and training as demonstrated by a record of funding, publications, and successful mentorship. The selected mentor(s) should demonstrate a clear commitment to the PI7#39;s training and be well qualified to contribute significantly to the development of the PI toward independence as a prostate cancer researcher.

Funding: The maximum period of performance is 2 years. The maximum allowable direct costs for the entire period of performance are $115,000 ($57,500 per year) plus indirect costs.All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Letter of Intent) due: June 6, 2012. Confidential Letters of Recommendation due: June 20, 2012. Application due: June 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 04/04/2012

SCAR Fellowship Programme 2012 – 2013

The SCAR Fellowship Programme is designed to encourage the active involvement of early career scientists and engineers in Antarctic scientific research, and to strengthen international capacity and cooperation in Antarctic research.

The programme is for PhD students, and those within 5 years of having completed a PhD, on the day of the deadline for applications, to undertake research at an institute in one of the 36 SCAR Member countries. In special cases (e.g. Maternity/Paternity leave), this 5 year period may be extended. Please contact the SCAR Secretariat (email info@scar.org) if you believe this to be the case. Topics for support should make a contribution to the scientific objectives of SCAR as embodied in the Standing Scientific Groups and both the current and upcoming Scientific Research Programmes. Awards will be up to US&$36;15,000, providing, as needed, economy–class round trip travel and a modest subsistence allowance for the fellowship period. The Fellow's home institute will bear all expenses incurred in his or her own nation (domestic travel, visa costs, etc.), and the host institute will waive any bench fees that they might normally charge trainees. Three to four awards will be made in total depending on the quality of the applications and the budget available.

In order to apply, candidates will be required to first contact and liaise with appropriate host Antarctic projects or programmes in order to secure the support and mentorship of an active research team capable of including them in their own research programme. The last date for submitting all components of the application package is by 13th June 2012. All proposals must be made on the appropriate forms, and submitted electronically.

Please refer to the Committ's website for submission details.

Last updated: 23/03/2012

Peer Reviewed Cancer Research Program (PRCRP) FY12 - Career Development Award

The PRCRP Career Development Award mechanism is being offered for the first time in FY12. To support the next generation of cancer research, this award offers opportunity for individuals in the early stages of their careers to obtain the funding, mentoring, and experience necessary to advance an independent position at the forefront of cancer research. The Career Development Award is intended to support novel and innovative research projects with an emphasis on discovery. Preliminary data is not required. The proposed research project should include a well–formulated, testable hypothesis based on strong scientific rationale and study design.

Funding: The maximum period of performance is 2 years. The maximum allowable direct costs for the entire period of performance are $240,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre-Applications due: June 19,2012. Pre-Application is required; Application submission is by invitation only. Application due: September 12, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 02/05/2012

Peer Reviewed Cancer Research Program (PRCRP) FY12 - Visionary Postdoctoral Fellowship Award

The PRCRP Visionary Postdoctoral Fellowship Award mechanism was first offered in FY11. Since then, 81 Visionary Postdoctoral Fellowship Award applications have been received, and 13 have been recommended for funding. To support the development of future generations of cancer researchers, this award offers an opportunity for a candidate postdoctoral fellow to collaborate with an earlyૻcareer independent, not yet tenured investigator serving as mentor in at least one of the FY12 PRCRP Topic Areas toward investigations that are relevant to military beneficiaries. The Visionary Postdoctoral Fellowship Award is intended to support exceptionally talented, recent medical or other doctoral graduates in their pursuit of cancer research during a postdoctoral fellowship with a focus on cutting–edge, innovative, high–risk/high–impact basic science or translational research that will have either short–term or long–term clinical impact. Translational research may include preclinical studies in animal models and/or human tissues that have a clear potential for translation into clinical applications. Correlative studies of existing clinical trials, and/or projects that develop clinical endpoints for clinical trials, may also be proposed. Clinical trials are not permitted under this award mechanism.

Funding: The maximum period of performance is 3 years. The maximum allowable direct costs for the entire period of performance are $240,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre-Applications due: June 19,2012. Pre-Application is required; Application submission is by invitation only. Application due: September 12, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 02/05/2012

Autism Research Program (ARP) FY12 – Idea Development Award

The ARP Idea Development Award mechanism was first offered in FY07. Since then, 237 Idea Development Award applications have been received, and 18 have been recommended for funding. The ARP Idea Development Award supports the development of innovative, high–impact ideas that advance the understanding of ASD and that ultimately will lead to improved outcomes for individuals with autism. Through the Idea Development Award, the ARP seeks to promote multidisciplinary collaborations (e.g., special education, biomedical science, preclinical research); to develop and validate biologically relevant animal models of autism (with appropriate justification for its relevance to a given subgroup); to investigate the implications of immunological response and ASD; and to leverage existing biological samples, clinical populations, and databases to provide power to test ideas.

Funding: The maximum period of performance is 3 years. The maximum allowable direct costs for the entire period of performance are $400,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Preproposal) : June 20, 2012. Pre–application is required; Application submissionis by invitation only. Application: September 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 04/05/2012

Autism Research Program (ARP) FY12 – Pilot Award

The ARP Pilot Award mechanism was first offered in FY11. Since then, 47 Pilot Award applications have been received, and 6 have been recommended for funding. The ARP Pilot Award supports conceptually innovative, high–risk/high–reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ASD forward. Research projects should include a testable hypothesis based on a strong scientific rationale. This award is not intended to support the continuation of existing studies or the next logical extension and/or incremental step. Through the Pilot Award, the ARP seeks to promote multidisciplinary collaborations (e.g., special education, biomedical science, preclinical research); to develop and validate biologically relevant animal models of autism (with appropriate justification for its relevance to a given subgroup); to investigate the implications of immunological response and ASD; and to leverage existing biological samples, clinical populations, and databases to provide power to test ideas. The Pilot Award emphasizes untested, novel, innovative, and potentially groundbreaking concepts, theories, paradigms, and/or methods. The award is designed to provide investigators with the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. The existence of preliminary data suggests that the proposed research does not meet the intent of this award mechanism. Therefore, preliminary data are not allowed. The strength of the application should be based on sound scientific rationale and logical reasoning.

Funding: The maximum period of performance is 2 years. The maximum allowable direct costs for the entire period of performance are $100,000 plus indirect costs. All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

Pre–Application (Preproposal) : June 20, 2012. Pre–application is required; Application submissionis by invitation only. Application: September 20, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 04/05/2012

New Scholars Program

TThe New Scholars Program supports projects to help early– to mid–career women scientists balance family responsibilities with demanding academic careers. New Scholars seeks to actively address the attrition rate of talented women scientists caused by work-life balance issues.

The Foundation provides one, two and three year grants to STEM institutions and organizations actively working towards a more equitable academia by: encouraging networking and collaborations among institutions and/or across STEM disciplines in ways that support the challenges of faculty and staff with family responsibilities; developing and implement strategies for advocacy and policy development to advance knowledge, awareness, and application of programs to retain, recruit and develop women in science; and enabling scientists to attend conferences, meetings, workshops and symposia that are critical to the development of a career in science by helping them with childcare and other family responsibilities when attending scientific gatherings.

Proposals are welcome for single–year grants in amounts between US$5,000 to US$50,000. Proposals will be accepted for multi–year programs (up to three years) for grant amounts of US$5,000 to $50,000 per year for a project total of $100,000. (msw)

All first round applications must be submitted online via The Elsevier Foundation's online grant application proposal system between May 1st and June 24th 2012. Applicants invited to submit a full proposal will be notified in July and asked to expand

Last updated: 15/05/2012

Advancing Understanding of Infantile Spasms Award

CURE promotes collaborative research that advances the search for a cure for epilepsy, and addresses the goal of "no seizures, no side effects." For this initiative, CURE seeks to fund investigators focused on finding a cure for infantile spasms. Both basic scientists and clinicians are encouraged to apply.

Infantile spasms (IS) is a rare childhood epilepsy syndrome that can have profoundly negative long–term developmental and cognitive consequences. Disease onset is typically between 3–7 months of age, and many children develop other seizure syndromes as they age. Infantile spasms is characterized by hypsarrhythmia on the EEG, a developmental feature unique to this syndrome. Importantly, a strong correlation has been noted between the presence of hypsarrhythmia plus spasms and cognitive and developmental delays. The most common treatments include hormones (ACTH), steroids (prednisone), or antiepileptic drugs (especially vigabatrin). Unfortunately, there remains a lack of consensus regarding the best initial therapeutic approach. Complete control of spasms can lead to improved long–term outcome; however, currently available treatments are not always effective and are often associated with substantial adverse effects.

CURE issues this directed Request for Applications (RFA) to accelerate the understanding of infantile spasms and advance a new, disease-modifying therapy into the clinic. This program will fund milestonedriven proposals for 1–3 years. CURE will commit up to $5 million over the next 3 years to fund proposals submitted for this initiative. CURE intends to fund multiple proposals as a part of this initiative. Applicants may request project periods of 1–3 years for direct costs appropriate and justifiable for the work proposed. Each item and its cost must be clearly described in the budget. A maximum of $1,000 ($1,500 for international applicants) per year can be budgeted for travel to scientific meetings. CURE encourages all awardees to attend the annual American Epilepsy Society meeting. Multi–year support is not automatic for any award and is contingent upon meeting milestones and progress reports being favorably reviewed.

Applications may be submitted by investigators exploring cutting-edge approaches to biomarker and model development that will aid in the identification and development of a disease modifying therapy or cure for IS. Applicants need to be willing to work in

Letter of Intent : All applicants must submit a Letter of Intent (LOI). The LOI should provide a brief description of the research plan that succinctly outlines the hypothesis to be tested, the specific aims, and proposed milestones that will serve to measure progress. LOIs should specifically address the purpose of this RFA as outlined above. All LOIs will be subjected to a review process. Scientific reviewers and the CURE Research Review Board will make recommendations to the CURE Board of Directors regarding which full proposals to invite. Only a subset of applicants will be invited to submit full proposals.

Please refer to the CURE's website for submission details.

Last updated: 15/05/2012

Clinical Trial Award FY12

Applications for the Peer Reviewed Orthopaedic Research Program (PRORP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The PRORP was established in fiscal year 2009 (FY09) to support research focused on optimizing recovery and restoration of function for military personnel with orthopaedic injuries sustained in combat or combat–related duties. Appropriations for the PRORP from FY09 through FY11 totaled $158.5 million (M). The FY12 appropriation is $30M.

The FY12 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high–impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat–related activities. Applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged.

Funding: The maximum period of performance is up to 4 years. The maximum funding for direct costs (plus indirect costs) is $2.5M.

Independent Investigators at or above the level of Assistant Professor (or equivalent) can apply. The Prepoposal due date is June 27, 2012.

For more details, go to http://cdmrp.army.mil/funding/pa/12prorpcta_pa.pdf

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 21/05/2012

Idea Development Award FY12

Applications for the Peer Reviewed Orthopaedic Research Program (PRORP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The PRORP was established in fiscal year 2009 (FY09) to support research focused on optimizing recovery and restoration of function for military personnel with orthopaedic injuries sustained in combat or combat–related duties. Appropriations for the PRORP from FY09 through FY11 totaled $158.5 million (M). The FY12 appropriation is $30M.

The FY12 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high–impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat–related activities. Applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged.

Funding: The maximum period of performance is up to 3 years. The maximum funding for direct costs (plus indirect costs) is $500K.

Independent Investigators at all academic levels can apply. The Prepoposal due date is June 27, 2012.

For more details, go to http://cdmrp.army.mil/funding/pa/12prorpida_pa.pdf

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 21/05/2012

Translational Research Partnership Award FY12

Applications for the Peer Reviewed Orthopaedic Research Program (PRORP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program. The PRORP was established in fiscal year 2009 (FY09) to support research focused on optimizing recovery and restoration of function for military personnel with orthopaedic injuries sustained in combat or combat–related duties. Appropriations for the PRORP from FY09 through FY11 totaled $158.5 million (M). The FY12 appropriation is $30M.

The FY12 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high–impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat–related activities. Applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged.

Funding: The maximum period of performance is up to 3 years. The maximum funding for direct costs (plus indirect costs) is $750K.

Independent Investigators at all academic levels can apply. The Prepoposal due date is June 27, 2012.

For more details, go to http://cdmrp.army.mil/funding/pa/12prorptrpa_pa.pdf

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 21/05/2012

Eleventh Annual Janet L. Norwood Award

The Section on Statistical Genetics and the Department of Biostatistics in the School of Public Health, University of Alabama at Birmingham (UAB) are pleased to request nominations for the Eleventh Annual Janet L. Norwood Award for Outstanding Achievement by a Woman in the Statistical Sciences. The award will be conferred on Wed 9/12/2012. The award recipient will be invited to deliver a lecture at the UAB award ceremony, and will receive all expenses, the award, and a $5,000 prize.

Eligible individuals are women who have completed their terminal degree, have made extraordinary contributions and have an outstanding record of service to the statistical sciences, with an emphasis on both their own scholarship and on teaching and leadership of the field in general and of women in particular and who, if selected, are willing to deliver a lecture at the award ceremony. For additional details about the award, please visit our website at http://www.soph.uab.edu/ssg/norwoodaward/aboutaward.

Deadline for receipt of nominations is Fri 6/29/2012. Electronic submissions of nominations are encouraged. The winner will be announced by Fri 7/6/2012.

Please refer to the Award website for submission details.

Last updated: 03/05/2012

FY 2012 Armed Forces Institute of Regenerative Medicine – II (AFIRM II)

The U.S. Army Medical Research and Materiel Command (USAMRMC), with the Office of Naval Research (ONR), the Air Force Medical Service, the Office of Research and Development – Department of Veterans Affairs (VA), the National Institutes of Health (NIH), and the Office of the Assistant Secretary of Defense for Health Affairs (the Sponsors) are soliciting applications for the AFIRM II program. The AFIRM II program is anticipated to be funded in Fiscal Year 2013 (FY13). One of the goals of the program is to position promising technologies and therapeutic/restorative practices for entrance into human clinical trials. The intent of the AFIRM II program is to fund basic through translational regenerative medicine research and development. Activities acceptable under this award may include basic scientific research, development of animal models, preclinical studies required for initiation of FDA–regulated human clinical trials, and Phase I – II human clinical trials. Therefore, it is not the intent to fund human clinical trials as a major component of this program. Pending the availability of funds, it is anticipated that additional human clinical trials will be solicited, evaluated, selected, and funded separately from the AFIRM II program in open competition.

Funding: The current funding level is anticipated for the AFIRM II program to be $15 million per year over five years for a total of $75 million, subject to the availability of funds. Please scope the proposed budget not to exceed $15 million per year including all costs (direct and indirect). Also, it is expected that the Offeror(s) will leverage funds from outside partners to further the goals of the AFIRM II program. All direct and indirect costs of any subaward contained in the Offeror(s) proposed budget must be included in the total direct costs of the primary award.

Pre–Application (Letter of Intent) Submission Deadline: 5:00 p.m. Eastern time (ET), July 2, 2012. Application Submission Deadline: 11:59 p.m. ET, July 11, 2012

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 26/04/2012

Target Identification in Lupus

The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus.

Individuals with doctoral degrees (MD, PhD or equivalent) are eligible to apply. Scientific independence as evidenced by direction of a research program, a publication record, or other experience that establishes scientific leadership is necessary to apply. The ALR does not impose geographic restrictions on its applicants, and investigators working anywhere in the world are eligible and encouraged to apply. The ALR is willing to appropriately support research in industry or collaborations between academia and industry.

Funding for the TIL award will be made for up to $200,000 per year (for a maximum of three years – total amount up to $600,000) including indirect costs. Funding for the third year is based on the successful submission of a non competitive progress report. The award amount will determined by the ALR's Board of Directors based on the results of the peer review process including recommendations from the ALR's Scientific Advisory Board. Detailed guidelines for application and submission are available on the websites listed above.

Deadlines associated with this grant program are as follows: Letter of Intent due to ALR by July 10, 2012. Grant Application due to ALR by August 10, 2012.

Please refer to the ALR website for submission details.

Last updated: 16/05/2012

UNESCO L'Oreal Co–Sponsored Fellowships Programme for Young Women in Life Sciences – 2013

Within the framework of the UNESCO Co–Sponsored Fellowships Scheme, a joint programme has been launched with the L'OREAL Corporate Foundation with a view to promoting the contribution of young women –from all over the world – in research developments in the field of life sciences. The UNESCO–L$OREAL fellowships scheme focuses on UNESCO's premise that people are the world's greatest resource and that innovation and excellence, especially among the young women community, deserve to be supported and encouraged through the concerted efforts of the international community. The award of the fellowships constitutes a key strategy through which impetus is being given to the enhancement of the role of women in devising scientific solutions to problems confronting humankind in the twenty–first century.

Candidates must already be engaged in pursuing research at the doctoral or post-doctoral level in one or allied fields of life sciences including biology, biochemistry, biotechnology, agriculture, medicine, pharmacy and physiology. Projects involving animal models (i.e. experimentation using vertebrate laboratory animals) are rejected, and proposals in the area of cosmetics research are NOT encouraged; preference is given to non cosmetic researches. The UNESCO–L'Oreal International Fellowships are designed to identify and reward fifteen deserving, committed and talented young women scientists, from all over the world, active in the field of life sciences. With a view to ensuring that a balanced geographical representation is made, a maximum of three young women, from each of the five geo–cultural regions of the world, will be awarded fellowships. Special attention will be given to candidatures from the Least Developed Countries(LDCs).

Please refer to the Programme website for submission details.

National Commission for UNESCO Contacts List | More...

Last updated: 17/05/2011

Advanced Postdoctoral Fellowship

The Advanced Postdoctoral Fellowship program is designed to attract qualified and promising health scientists, to provide an opportunity to receive full time research training, and to assist these promising individuals in transitioning from a fellowship to an independent (faculty–level) position. JDRF envisions the 3–year award term as a period in which fellows will receive critical research training that will position them to work at the leading edge of their chosen field. An additional, optional 1–year transition award will further assist fellows to proceed to independent faculty or research appointments and will serve as a bridge between the fellowship and independent competitive research funding. During the fellowship phase, the applicant is required to work with a sponsor who can provide a training environment conducive to beginning a career in diabetes–relevant research. At the time of activating the award, the applicant must have a doctoral degree (PhD, MD, DMD, DVM, or equivalent) from an accredited institution and must not be simultaneously serving an internship or residency.

The fellowships are intended for those in a relatively early stage of their career. Generally, their first degree (PhD, MD, DMD, DVM, or equivalent) will have been received no more than 5 years before the fellowship. Applicants who have completed 1–3 years of postdoctoral training and now show extraordinary promise may wish to apply for this advanced award. Alternatively, exceptionally qualified and talented individuals are encouraged to apply at the beginning of their careers. This program is targeted to those who would benefit from postdoctoral research training in preparation for later faculty appointments (therefore, applicants may not have faculty appointments). There are no citizenship requirements for this program. To assure continued excellence and diversity among applicants and awardees, JDRF welcomes applications from all qualified individuals and encourages applications from persons with disabilities women and members of minority groups underrepresented in the sciences.

Awards will be made for a duration of up to 3 years, assuming satisfactory progress. The fellowship term is 12 months for each fellowship year, and fellows must devote 100% of their effort to the project outlined in the application. Budgets up to USD 90,000 per year for up to 3 years may be requested. The stipend request must be consistent with the amounts shown in Table 2 (refer to website) based on years of relevant postdoctoral experience. Salary support for additional staff is not allowable.

Please refer to the Foundation's website for submission requirements.

Last updated: 08/05/2012

Career development Award

JDRF fosters the development and productivity of the best and the brightest established independent researchers who will bridge the gap between the bench and bedside. The primary purpose of the Career Development Award is to attract qualified and promising scientists early in their faculty careers and to give them the opportunity to establish themselves in areas that reflect the JDRF research emphasis areas. In the five–year term of the award, awardees will focus their research efforts on a subject directly related to JDRF mission goals and research priorities, and position themselves to work at the leading edge of type 1 diabetes research. These awards are designed to assist exceptionally promising investigators. Although JDRF is especially interested in fostering careers in clinical investigation, Career Development Awards may emphasize either basic or clinical topics.

The Career Development Award is intended for individuals in a relatively early stage of their career. Ordinarily, their first degree (MD, PhD, DMD, DVM, or equivalent) will have been received at least three but not more than seven years before the award. The applicant must hold an academic faculty–level position (including assistant professor or equivalent) at the time of the application, at a university, health science center, or comparable institution with strong, well–established research and training programs for the chosen area of interest. There are no citizenship requirements for this program. To assure continued excellence and diversity among applicants and awardees, JDRF welcomes applications from all qualified individuals and encourages applications from persons with disabilities women and members of minority groups underrepresented in the sciences.

Career Development Award research may be conducted at foreign and domestic, for–profit and nonprofit, and public and private organizations – such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.

The award is up to USD 150,000 per year, including indirect costs. These funds may be used for a research allowance, which can include a technician, supplies, equipment and travel up to USD 2000 per year. The awards are renewable pending satisfactory prog

Please refer to the Foundation's website for submission requirements.

Last updated: 03/05/2012

Early Career, Patient–Oriented Diabetes Research Award

The JDRF Early Career Patient–Oriented Diabetes Research Award will provide crucial support to investigators who plan to pursue a career in diabetes-related clinical investigation. These prestigious awards are made in the later stages of training and include the ability for recipients to transition to independent faculty or research appointments. The award has a five-year term.

The successful candidate will have an MD or MD–PhD, hold an appointment or joint appointment in a subspecialty of clinical medicine, and conduct human clinical research. In exceptional circumstances, non–MD candidates will be considered if their work is likely to contribute significantly to a clinical outcome. The candidate must hold an appointment or joint appointment in a clinical department. For the purposes of this award, clinical research is defined as research conducted with human subjects for which the investigator directly interacts with the subjects. Areas of relevant research can include (but are not limited to): 1) mechanisms of human disease; 2) therapeutic interventions; 3) clinical trials; 4) the development of new technologies.

Awardees will be required to provide an annual progress report. Awards are renewable for a maximum of four years. Awardees must devote at least 75% of professional effort to the conduct of type 1 diabetes–related clinical research during the period of the award. Awards are in the amount of up to USD 150,000 total costs per year, including indirect costs. Up to USD 75,000 of this may be requested for research allowance, which can include a technician, supplies, equipment, and travel up to USD 2,000 per year. Salary request must be consistent with the established salary structure of the applicant's institution, and equipment in years other that the first must be strongly justified. Indirect costs (excluding equipment) cannot exceed 10%.

Please refer to the Foundation's website for submission requirements.

Last updated: 08/05/2012

Postdoctoral Fellowship

Postdoctoral fellowships are designed to attract qualified, promising scientists entering their professional career in the diabetes research field. The applicant is required to work with a sponsor who can provide a training environment conducive to beginning a career in type 1 diabetes–relevant research. At the time of activating the award, the applicant must have a doctoral degree (PhD, MD, DMD, DVM), or the equivalent from an accredited institution and must not be simultaneously serving an internship or residency.

There are no citizenship requirements for this program. To assure continued excellence and diversity among applicants and awardees, JDRF welcomes applications from all qualified individuals and encourages applications from persons with disabilities women and members of minority groups underrepresented in the sciences.

Awards are for three years, assuming satisfactory progress. The fellowship term is 12 months for each fellowship year, and fellows must devote 100% of their effort to the project outlined in the fellowship application. Recipients of the JDRF postdoctoral fellowship award cannot hold another postdoctoral fellowship at the same time.

Please refer to the Foundation's website for submission requirements.

Last updated: 08/05/2012

Prostate Cancer Research Program (PCRP) – Health Disparity Research Award FY12

The PCRP Health Disparity Research Award mechanism was introduced in FY01. Since then, 185 applications have been received, and 50 have been recommended for funding. The Health Disparity Research Award (HDRA) supports new ideas based on innovative concepts or methodologies for prostate cancer health disparity research with the potential to make an important contribution towards eliminating death and suffering from prostate cancer. Studies proposed for this award mechanism are expected to improve the understanding of, and ultimately eliminate, disparities in prostate cancer incidence, morbidity, and mortality. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity. Appropriate health disparity areas include, but are not limited to, race and ethnicity, socioeconomic status, access to or differing standards of health care, insurance status, age, geography, and cultural beliefs.

Funding: The maximum period of performance is 3 years. The maximum allowable direct –or – total costs for the entire period of performance are $450,000 plus indirect costs for both Established and New Investigators.

Pre–Application (Letter of Intent) due: July 26, 2012. Confidential Letters of Recommendation (Nested Traineeship Option only) due: August 9, 2012. Application due: August 9, 2012.

Monash information required for applications to USA organisations is available on our website at | More...

Last updated: 03/04/2012

Sleep Health Education Grant 2013

This grant is designed to support the development of creative and innovative programmes for education (of the public or non–sleep health professionals) and/or outreach on sleep health–related research for a variety of audiences.

This initiative aims to accelerate the transfer of recent scientific advances and established knowledge in sleep health and circadian/sleep biology to health professionals and/or the public at large. Applicants may propose to develop tools and/or strategies to advance community awareness through broader public health initiatives; or decrease sleep health disparities and improve health equality. Specific types of sleep education research grants supported by this programme could include innovative educational approaches designed to: improve knowledge transfer to clinicians (non–sleep specialists), allied health and/or community health care providers about sleep and sleep disorders, or transfer knowledge gained from sleep and circadian rhythm research into the broad public arena, for example child care venues, schools, workplaces, aged care and community groups that may or may not be brought together around health issues. Applications may include social marketing strategies, research–practice partnership models, community–based or clinic–based participatory research, or new models that foster partnerships among researchers, providers and the public. Successful programmes will have plans for portability and adoption in multiple settings and have built in education research methodology to evaluate validity and program efficacy. Proposals must have plans to bring sleep researchers together with appropriate communities of healthcare providers, health services, communities and/or other stakeholders. Projects that develop educational strategies that are portable and sustainable and have built in metrics for demonstrating measurable outcomes and assess potential for adoption or replication in other settings will be well regarded.

The grant is open to individuals or small teams who work in Australia or New Zealand, and the health education work must be undertaken in Australia or New Zealand. The applicant should not have received other substantial sources of support for their proposal. The maximum value of the grant is $20,000. The duration of the grant is normally for one year. Proposals for a single $20,000 grant distributed over two years will also be considered. (elg)

Please refer to the Foundation 's website for submission details.

Last updated: 10/05/2012

Wiley Prize in Biomedical Sciences 2012

The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality, and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee's significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research which champions novel approaches and challenges accepted thinking in the biomedical sciences.

Eligible nominees are exceptional Ph.D. and M.D. scientists whose research has set the standard for excellence. More than one nomination can be made from the same organization. International nominations are eligible and the number of years in a position is not relevant to the nomination. This international award is presented annually and consists of a $35,000 prize and a luncheon in honor of the recipient. The award is presented at a ceremony at The Rockefeller University, where the recipient delivers an honorary lecture as part of The Rockefeller University Lecture Series.

The evaluations of each nominee will depend on the information provided in the nomination packages. Therefore it is important that the nominations be as complete, current, and accurate as possible. Please refer to the Foundation's website for submission details.

Last updated: 23/01/2012

Research Interests of the Air Force Office of Scientific Research

The Air Force Office of Scientific Research (AFOSR) manages the basic research investment for the U.S. Air Force (USAF). As a part of the Air Force Research Laboratory (AFRL), AFOSR's technical experts foster and fund research within the Air Force Research Laboratory, universities, and industry laboratories to ensure the transition of research results to support USAF needs. Using a carefully balanced research portfolio, research managers seek to create revolutionary scientific breakthroughs, enabling the Air Force and U.S. industry to produce world–class, militarily significant, and commercially valuable products.

It is anticipated the awards will be made in the form of a grant, cooperative agreement or contract. AFOSR reserves the right to select and fund for award; all, some, part or none of the proposals in response to this announcement.

The focus of AFOSR is on research areas that offer significant and comprehensive benefits to our national warfighting and peacekeeping capabilities. These areas are organized and managed in three scientific directorates: Aerospace, Chemical and Material Sciences, Physics and Electronics, and Mathematics, Information and Life Sciences. The research activities managed within each directorate are summarized in this section.

Full Program Announcement | More...

Homepage | More...

Last updated: 13/10/2010

Research Grants

FIA provides support for research projects conducted by established investigators relevant to clinical and scientific problems associated with food allergies.

Applications are reviewed throughout the year. Researchers interested in solving the clinical and scientific problems associated with food allergies are encouraged to apply for funding.

Last updated: 23/03/2009

International Peace and Security: Asia Security Initiative (ASI)

The sponsor is looking for ways to build their capacity for security policy research and develop policy recommendations on the most important security challenges facing Asia–Pacific nations.

OBJECTIVES: The sponsor is looking for concept papers that would assit in their Asia Security Initiative covering the sponsor'srecognized areas of focus: Regional Security Cooperation: They will advise policymakers on how to better use multilateral institutions, bilateral relationships and alliances to prevent conflict, manage differences, and foster peace and security. Northeast Asia: They will develop actionable plans for international cooperation to decrease tensions over North Korea, Taiwan and between Northeast Asian nations. Internal Challenges: They will recommend regional cooperation to help Asia–Pacific nations manage internal challenges, from increasing domestic demand for scarce resources to violent internal conflict. Grants are awarded in the strategy areas outlined above for policy research linked to prescriptions for action, outreach to the public and policymakers, and fellowship programs.

Concept papers will be accepted by June 1, 2010 for consideration by the Foundation board in September and by December 15, 2010 for consideration by the Foundation board in March, 2011.

Funding duration will be for 18 months.

Last updated: 06/04/2009

International Program: Global Security and Sustainability

The Program on Global Security and Sustainability seeks to protect the security and well–being of people and the environment around the world. To meet these broad objectives, the international program focuses on several areas of concern. The Foundation works to encourage peace within and among countries, conserve global biological diversity, support responsible reproductive choices and reduction of maternal mortality, and protect human rights and strengthen the system of international justice.

Letters of inquiry are invited at any time, with the following exceptions: Concept papers for the International Peace and Security Asia – Security Initiative Policy Research Grants will be accepted June 1 and December 15, 2009.

Last updated: 06/04/2009

Various programs

The National Institute of Health (NIH), administered by a US government Department, offers a vast range of funding oppurtunities for research on an international scale.

Closing dates for funding opportunities vary throughout the year. Please see individual opportunities for details.

Last updated: 02/01/2008

Exploratory/Developmental Research Grant Award

Participating institutes of the National Institutes of Health provide support to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects.

The NIH seeks to foster the introduction of novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. Applications should be exploratory and novel. These studies should break new ground or extend previous discoveries toward new directions or applications.

The applicant may request a project period of up to two years with a combined budget for direct costs of up US$275,000 for the two year period. Normally, no more than US$200,000 may be requested in any single year.

Last updated: 02/05/2007

Research Project Grant

The Research Project Grant (R01) is an award to support a discrete, specified, circumscribed project to be performed by named Project Directors/Principal Investigators (PDs/PIs) in areas representing the investigators' specific interests and competencies, based on the mission of the NIH, to support health–related research and development.

The R01 research plan proposed by the applicant institution/organization must be related to the stated program interests of one or more of the NIH Institutes and Centers (ICs) based on descriptions of their programs.

Last updated: 02/05/2007

Grants Program

The sponsor seeks to improve the health of children through research that offers substantial promise for meaningful advances in the prevention and treatment of children's diseases.

The Fund's median award is $230,000, with the majority between $150,000–$300,000. The Fund will participate in the payment of indirect costs up to an amount of seven percent of the yearly Grant budget excluding equipment allocations.

Last updated: 11/02/2008

Breast Cancer Research Program – Anticipated Funding Opportunities Fiscal Year 2011 (FY11)

The Department of Defense Breast Cancer Research Program (BCRP) is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP). Congressional funds for the Fiscal Year 2011 (FY11) BCRP have not yet been appropriated. However, the BCRP is providing the information in this pre–announcement to allow investigators time to plan and develop applications. The BCRP anticipates offering the following award mechanisms for FY11 pending availability of congressional funds. This pre–announcement should not be construed as an obligation by the government.

There are a range of awards open for 2011 under the Breast Cancer Research Program. These include the Postdoctoral Fellowship Award, Era of Hope Scholar Award, Innovator Award, Transformative Vision Award and Idea Award. For further details of the pre–announcement of each award please visit the website provided.

Please note that this is a pre–announcement only. Further information regarding these funding opportunities including actual closing dates will follow as soon as available.

Last updated: 15/12/2010